Icon PLC (ICLR) Q4 2025 Earnings Call Highlights: Strong Bookings Amid Revenue Challenges2026-05-2823%External coverage
FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer2026-02-1823%External coverage
ICON Public Limited Company (ICLR) Delays Earnings Amid Internal Investigation2026-02-1432%External coverage